Addex Therapeutics (APE) Regains Global Rights to GABAB PAM Portfolio

Addex Therapeutics regained full global rights to all GABAB positive allosteric modulator assets from Indivior, including a candidate for substance use disorders, and will evaluate new partnerships or internal advancement.Material DetailsContext by AI AnalystThis is an early-to-mid stage strategic…